Obermatt
See Similar Stocks →

Flags

Financial distress

Pyridam Farma

JKT:PYFA · ID1000075609
PharmaceuticalsSmall

360

3
Medium confidence — indicative
EV / EBIT45
Price / Owner Earnings77
Owner Earnings Yield1
Dividend Yield1
Price/Sales71
EV / Gross Profit20
Price/Book24
Return on Capital56
Cash Return on Capital47
Return on Equity36
EBIT Margin36
Gross Profitability33
Accruals25
Owner Earnings Margin29
Sales growth56
Profit growth33
Reinvestment68
Price momentum29
Debt load1
Refinancing70
Debt Payback1
Liquidity25
Analyst ratings—
Expectations trend—
Market mood6
Value Creation0/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Pyridam Farma doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountrySingapore
IndustryPharmaceuticals
SizeSmall
TypePublic Company
ExchangeIDX
Employees277
Websitepyfa.co.id
ISINID1000075609
Last UpdateApr 2, 2026
Indices
IDX Composite (Indonesia)
Themes
DermatologyRespiratoryNutraceuticalLifestyleHealth DiagnosticsPackaging ServicesCardiovascularPain ManagementWomen's HealthHealth CareMedicalPharmaceutical

Description

PT Pyridam Farma Tbk engages in the development, production, and trading of pharmaceuticals. Business Segments The company operates through pharmaceutical products, esthetic, and toll manufacturing services and medical equipment products. Pharmace…

Analysis

Middle-of-the-road

PT Pyridam Farma Tbk sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is mixed; the safety picture is fragile. The company scores 0/20 on our value-creation score: not creating value. Analyst sentiment is cautious.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
11
2026

All-time high

28

Mar 2026

All-time low

11

Jun 2026

Average rank

20

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
71
—
—
—
Price/Earnings
—
—
—
—
Price/Book
24
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
39
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Pyridam Farma with its peers
Feng Hsin Steel
TAI:2015
82
CountryTaiwan
IndustryMetals & Mining
SizeMedium
Full Stock Analysis →
Kyongbo Pharmaceutical
KSC:214390
11
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Pulmuone Corporate
KSC:017810
50
CountrySouth Korea
IndustryFood Products
SizeMedium
Full Stock Analysis →
Chagee Holdings
NSQ:CHA
84
CountryChina
IndustryHotels, Restaurants & Leisure
SizeLarge
Full Stock Analysis →
PT Wahana Interfood Nusantara
JKT:COCO
45
CountrySingapore
IndustryFood Products
SizeSmall
Full Stock Analysis →
National Plastic
KSC:004250
17
CountrySouth Korea
IndustryContainers & Packaging
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →